Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?

Eur Heart J. 2019 Dec 7;40(46):3754-3756. doi: 10.1093/eurheartj/ehz005.

Authors

Ahsan A Khan¹, Gregory Y H Lip^{1

2}

Affiliations

¹ Liverpool Centre for Cardiovascular Sciences, Institute of Ageing and Chronic Disease, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, UK.
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Søndre Skovvej 15, Forskningens Hus, Aalborg, Denmark.

PMID: 30668731
DOI: 10.1093/eurheartj/ehz005

No abstract available

MeSH terms

Anticoagulants / therapeutic use*
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy
Coronary Disease / drug therapy*
Humans
Secondary Prevention / methods
Stroke / prevention & control
Treatment Outcome

Substances

Anticoagulants